These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 8075077)

  • 1. Design of potent and selective inhibitors of myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Safrany ST; Mills SJ; Liu C; Lampe D; Noble NJ; Nahorski SR; Potter BV
    Biochemistry; 1994 Sep; 33(35):10763-9. PubMed ID: 8075077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic analysis of novel inhibitors of inositol polyphosphate metabolism.
    Hansbro PM; Foster PS; Liu C; Potter BV; Denborough MA
    Biochem Biophys Res Commun; 1994 Apr; 200(1):8-15. PubMed ID: 8166746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition.
    Safrany ST; Wilcox RA; Liu C; Potter BV; Nahorski SR
    Eur J Pharmacol; 1992 Jul; 226(3):265-72. PubMed ID: 1330634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of synthetic D-6-deoxy-myo-inositol 1,4,5-trisphosphate with the Ca2(+)-releasing D-myo-inositol 1,4,5-trisphosphate receptor, and the metabolic enzymes 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; Nahorski SR; Dubreuil D; Cleophax J; Gero SD; Potter BV
    FEBS Lett; 1991 Jan; 278(2):252-6. PubMed ID: 1846823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of partial agonists with low intrinsic activity at the inositol-1,4,5-trisphosphate receptor.
    Safrany ST; Wilcox RA; Liu C; Dubreuil D; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Apr; 43(4):499-503. PubMed ID: 8386304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification at C2 of myo-inositol 1,4,5-trisphosphate produces inositol trisphosphates and tetrakisphosphates with potent biological activities.
    Wilcox RA; Safrany ST; Lampe D; Mills SJ; Nahorski SR; Potter BV
    Eur J Biochem; 1994 Jul; 223(1):115-24. PubMed ID: 8033885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-Hydroxyethyl-alpha-D-glucopyranoside-2,3',4'-trisphosphate, a novel, metabolically resistant, adenophostin A and myo-inositol-1,4,5-trisphosphate analogue, potently interacts with the myo-inositol-1,4,5-trisphosphate receptor.
    Wilcox RA; Erneux C; Primrose WU; Gigg R; Nahorski SR
    Mol Pharmacol; 1995 Jun; 47(6):1204-11. PubMed ID: 7603461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of selective non-Ca(2+)-mobilizing inhibitors of D-myo-inositol 1,4,5-trisphosphate 5-phosphatase.
    Lampe D; Liu C; Potter BV
    J Med Chem; 1994 Apr; 37(7):907-12. PubMed ID: 8151617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes.
    Hirata M; Watanabe Y; Yoshida M; Koga T; Ozaki S
    J Biol Chem; 1993 Sep; 268(26):19260-6. PubMed ID: 8396130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inositol-1,3,4,5-tetrakisphosphate induces calcium mobilization via the inositol-1,4,5-trisphosphate receptor in SH-SY5Y neuroblastoma cells.
    Wilcox RA; Challiss RA; Liu C; Potter BV; Nahorski SR
    Mol Pharmacol; 1993 Oct; 44(4):810-7. PubMed ID: 8232232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic phosphorothioate-containing analogues of inositol 1,4,5-trisphosphate mobilize intracellular Ca2+ stores and interact differentially with inositol 1,4,5-trisphosphate 5-phosphatase and 3-kinase.
    Safrany ST; Wojcikiewicz RJ; Strupish J; McBain J; Cooke AM; Potter BV; Nahorski SR
    Mol Pharmacol; 1991 Jun; 39(6):754-61. PubMed ID: 1646949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium release activity and metabolism of inositol 1,4,5-trisphosphate in T cells. Modulation by novel inositol 1,4,5-trisphosphate 5-phosphatase inhibitors.
    Ward SG; Lampe D; Liu C; Potter BV; Westwick J
    Eur J Biochem; 1994 Jun; 222(2):515-23. PubMed ID: 8020489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of 1L-chiro-inositol 2,3,5-trisphosphorothioate, the first partial agonist at the platelet myo-inositol 1,4,5-trisphosphate receptor.
    Liu C; al-Hafidh J; Westwick J; Potter BV
    Bioorg Med Chem; 1994 Apr; 2(4):253-7. PubMed ID: 7922136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of phosphorofluoridate analogues of D-myo-inositol 1,4,5-trisphosphate to assess the involvement of ionic interactions in its recognition by the receptor and metabolising enzymes.
    Yoshimura K; Watanabe Y; Erneux C; Hirata M
    Cell Signal; 1999 Feb; 11(2):117-25. PubMed ID: 10048789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-myo-inositol 1,4,5-trisphosphate analogues substituted at the 3-hydroxyl group.
    Hirata M; Watanabe Y; Kanematsu T; Ozaki S; Koga T
    Biochim Biophys Acta; 1995 Jun; 1244(2-3):404-10. PubMed ID: 7599161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase.
    Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV
    FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate.
    Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S
    Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular recognition at the myo-inositol 1,4,5-trisphosphate receptor. 3-position substituted myo-inositol 1,4,5-trisphosphate analogues reveal the binding and Ca2+ release requirements for high affinity interaction with the myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Challiss RA; Traynor JR; Fauq AH; Ognayanov VI; Kozikowski AP; Nahorski SR
    J Biol Chem; 1994 Oct; 269(43):26815-21. PubMed ID: 7929418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic D- and L-enantiomers of 2,2-difluoro-2-deoxy-myo-inositol 1,4,5-trisphosphate interact differently with myo-inositol 1,4,5-trisphosphate binding proteins: identification of a potent small molecule 3-kinase inhibitor.
    Safrany ST; Sawyer DA; Nahorski SR; Potter BV
    Chirality; 1992; 4(7):415-22. PubMed ID: 1334423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defining the minimal structural requirements for partial agonism at the type I myo-inositol 1,4,5-trisphosphate receptor.
    Wilcox RA; Fauq A; Kozikowski AP; Nahorski SR
    FEBS Lett; 1997 Feb; 402(2-3):241-5. PubMed ID: 9037203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.